Viewing Study NCT03145220


Ignite Creation Date: 2025-12-25 @ 4:17 AM
Ignite Modification Date: 2026-03-02 @ 4:24 PM
Study NCT ID: NCT03145220
Status: UNKNOWN
Last Update Posted: 2018-06-26
First Post: 2016-06-22
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Immunomodulation of EA-230 Following On-pump Coronary Artery Bypass Grafting (CABG)
Sponsor: Radboud University Medical Center
Organization:

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Systemic Inflammatory Response Syndrome View
None Coronary Artery Bypass Grafting View
Keywords:

Keywords

Keyword Brief Keyword Text View
None EA-230 View
None Systemic Inflammatory Response Syndrome View
None Acute Kidney Injury View
None Interleukin-6 View
None Safety View
None Tolerability View
None Phase II View
None Randomized clinical trial View